NASDAQ: VRTX
Vertex Pharmaceuticals Inc Stock Ownership - Who owns Vertex Pharmaceuticals?

Insider buying vs selling

Have Vertex Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
David AltshulerEVP Chief Scientific Officer2025-03-133,231$510.00
$1.65MSell
Ourania TatsisEVP Chief Reg. Quality Off.2025-03-103,242$499.99
$1.62MSell
David AltshulerEVP Chief Scientific Officer2025-03-103,231$500.00
$1.62MSell
Charles F. Wagner Jr.EVP Chief Financial Officer2025-03-103,298$500.00
$1.65MSell
Ourania TatsisEVP Chief Reg. Quality Off.2025-03-044,058$485.49
$1.97MSell
David AltshulerEVP Chief Scientific Officer2025-03-033,231$490.00
$1.58MSell
David AltshulerEVP Chief Scientific Officer2025-02-271,272$480.00
$610.56kSell
Edward Morrow Atkinson IiiEVP Chief Technical Ops. Off.2025-02-272,650$475.34
$1.26MSell
Ourania TatsisEVP Chief Reg. Quality Off.2025-02-27530$475.34
$251.93kSell
Edward Morrow Atkinson IiiEVP Chief Technical Ops. Off.2025-02-262,482$479.61
$1.19MSell

1 of 10

VRTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VRTX insiders and whales buy or sell their stock.

VRTX Shareholders

What type of owners hold Vertex Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Capital World Investors11.03%28,325,695$13.53BInstitution
Vanguard Group Inc9.06%23,258,288$11.11BInstitution
Blackrock Inc8.50%21,825,470$10.42BInstitution
State Street Corp4.67%11,979,405$5.72BInstitution
Capital Research Global Investors4.06%10,428,951$4.98BInstitution
Fmr LLC3.59%9,219,046$4.40BInstitution
Jpmorgan Chase Co2.46%6,313,107$3.01BInstitution
Wellington Management Group LLP2.30%5,916,084$2.83BInstitution
Geode Capital Management LLC2.20%5,648,236$2.70BInstitution
Jennison Associates LLC1.68%4,317,762$2.06BInstitution

1 of 3

VRTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VRTX91.81%1.49%Net SellingNet Selling
REGN69.81%30.19%Net Selling
ARGX56.15%0.00%
ALNY82.31%17.69%Net SellingNet Selling
ONC3.15%32.86%Net SellingNet Buying

Vertex Pharmaceuticals Stock Ownership FAQ

Who owns Vertex Pharmaceuticals?

Vertex Pharmaceuticals (NASDAQ: VRTX) is owned by 91.81% institutional shareholders, 1.49% Vertex Pharmaceuticals insiders, and 6.70% retail investors. Capital World Investors is the largest individual Vertex Pharmaceuticals shareholder, owning 28.33M shares representing 11.03% of the company. Capital World Investors's Vertex Pharmaceuticals shares are currently valued at $13.89B.

If you're new to stock investing, here's how to buy Vertex Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.